Bone Biologics Corp. Files 2024 10-K

Ticker: BBLGW · Form: 10-K · Filed: Feb 26, 2025 · CIK: 1419554

Bone Biologics Corp 10-K Filing Summary
FieldDetail
CompanyBone Biologics Corp (BBLGW)
Form Type10-K
Filed DateFeb 26, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-K, annual-report, financials

TL;DR

Bone Biologics filed its 2024 10-K. Full financials and biz update out.

AI Summary

Bone Biologics Corp. filed its 2024 10-K on February 26, 2025, reporting on its fiscal year ending December 31, 2024. The company, incorporated in Delaware and headquartered in Burlington, MA, operates in the orthopedic, prosthetic & surgical appliances & supplies industry. The filing covers its financial performance and business operations for the fiscal year 2024.

Why It Matters

This filing provides investors and stakeholders with a comprehensive overview of Bone Biologics Corp.'s financial health and strategic direction for the fiscal year 2024, crucial for investment decisions.

Risk Assessment

Risk Level: medium — As a publicly traded company, Bone Biologics Corp. faces inherent market and operational risks detailed within its 10-K filing.

Key Numbers

  • 2024-12-31 — Fiscal Year End (Reporting period covered by the 10-K)
  • 2025-02-26 — Filing Date (Date the 10-K was submitted to the SEC)

Key Players & Entities

  • Bone Biologics Corp. (company) — Filer of the 10-K
  • 2024-12-31 (date) — Fiscal year end
  • 2025-02-26 (date) — Filing date
  • Burlington, MA (location) — Company headquarters
  • 0001419554 (company_id) — Central Index Key

FAQ

What is the primary business of Bone Biologics Corp.?

Bone Biologics Corp. operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, as indicated by its SIC code 3842.

When did Bone Biologics Corp. file its 10-K for the fiscal year 2024?

Bone Biologics Corp. filed its 10-K for the fiscal year 2024 on February 26, 2025.

Where is Bone Biologics Corp. headquartered?

Bone Biologics Corp. is headquartered at 2 Burlington Woods Drive, Suite 100, Burlington, MA 01803.

What is the Central Index Key (CIK) for Bone Biologics Corp.?

The Central Index Key for Bone Biologics Corp. is 0001419554.

What is the SEC file number for Bone Biologics Corp.?

The SEC file number for Bone Biologics Corp. is 001-40899.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on February 26, 2025 regarding Bone Biologics Corp (BBLGW).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.